Detrimental Contribution of the Toll-Like Receptor (TLR)3 to Influenza A Virus–Induced Acute Pneumonia
暂无分享,去创建一个
Lena Alexopoulou | Mustapha Si-Tahar | R. Flavell | N. Escriou | M. Chignard | M. Si-Tahar | L. Alexopoulou | V. Balloy | Richard Flavell | R. L. Goffic | M. Lagranderie | Nicolas Escriou | Michel Chignard | Viviane Balloy | Ronan Le Goffic | Micheline Lagranderie
[1] C. Loddenkemper,et al. Self-Limitation of Th1-Mediated Inflammation by IFN-γ1 , 2006, The Journal of Immunology.
[2] Shizuo Akira,et al. Innate immune recognition of viral infection , 2006, Nature Immunology.
[3] T. Doran,et al. Immune responses to dsRNA: Implications for gene silencing technologies , 2005, Immunology and cell biology.
[4] Martin F. Bachmann,et al. Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection , 2005, Journal of Virology.
[5] D. Woodland. Faculty Opinions recommendation of Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections. , 2005 .
[6] I. Haga,et al. The role of Toll-like receptors in the host response to viruses. , 2005, Molecular immunology.
[7] R. Schumann,et al. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. , 2005, The Lancet. Infectious diseases.
[8] S. Akira,et al. Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus* , 2005, Journal of Biological Chemistry.
[9] G. Sen,et al. Transcriptional signaling by double-stranded RNA: role of TLR3. , 2005, Cytokine & growth factor reviews.
[10] K. Hartshorn,et al. Novel strategies for prevention and treatment of influenza , 2005, Expert opinion on therapeutic targets.
[11] E. Kurt-Jones,et al. Viruses and Toll-like receptors. , 2004, Microbes and infection.
[12] E. Fikrig,et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis , 2004, Nature Medicine.
[13] Takeshi Kurata,et al. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. , 2004, Japanese journal of infectious diseases.
[14] P. Palese,et al. Influenza: old and new threats , 2004, Nature Medicine.
[15] F. Hayden. Pandemic Influenza: Is an Antiviral Response Realistic? , 2004, The Pediatric infectious disease journal.
[16] T. Toner,et al. Comparative study of influenza virus replication in Vero and MDCK cell lines. , 2004, Journal of virological methods.
[17] A. Williams,et al. Ménage à trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung , 2004, Clinical and experimental immunology.
[18] K. Tyler,et al. Does Toll-like receptor 3 play a biological role in virus infections? , 2004, Virology.
[19] R. Flavell,et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[20] R. Bronson,et al. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[21] L. Zhang,et al. Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement , 2003, Journal of Clinical Virology.
[22] C. Amici,et al. NF‐κB and virus infection: who controls whom , 2003, The EMBO journal.
[23] B. Vargaftig,et al. Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production , 2003, Immunology.
[24] A. Linde,et al. Treatment and Prevention of Influenza: Swedish Recommendations , 2003, Scandinavian journal of infectious diseases.
[25] Y. Guan,et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.
[26] D. McGavern,et al. T cells in the central nervous system: the delicate balance between viral clearance and disease. , 2002, The Journal of infectious diseases.
[27] A. Abbas,et al. Interferon γ Is Required for Activation-induced Death of T Lymphocytes , 2002, The Journal of experimental medicine.
[28] G. Karupiah,et al. FIELDS VIROLOGY, 4TH EDITION , 2002 .
[29] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[30] F. Hayden,et al. Symptom pathogenesis during acute influenza: Interleukin‐6 and Other cytokine responses , 2001, Journal of medical virology.
[31] K. Melén,et al. Survey Molecular Pathogenesis of Influenza a Virus Infection and Virus-induced Regulation of Cytokine Gene Expression , 1998 .
[32] A. Cerwenka,et al. Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology. , 2001, The American journal of pathology.
[33] M. Chignard,et al. Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[34] K. Reeth. Cytokines in the pathogenesis of influenza. , 2000 .
[35] K. Van Reeth. Cytokines in the pathogenesis of influenza. , 2000, Veterinary microbiology.
[36] Jeffrey S. Young,et al. Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. , 1998, The Journal of clinical investigation.
[37] D. Kioussis,et al. Contribution of Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model , 1998, The Journal of experimental medicine.
[38] S. Akira,et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. , 1998, Immunity.
[39] S. Kostense,et al. Interleukin 12 administration enhances Th1 activity but delays recovery from influenza A virus infection in mice. , 1998, Antiviral research.
[40] C. Bona,et al. Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice , 1996, Journal of virology.
[41] A. Alcamí,et al. Receptors for gamma-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus. , 1996, Trends in microbiology.
[42] F. Ennis,et al. Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice. , 1981, Journal of immunology.
[43] R. Couch,et al. Effects of Low- and High-Passage Influenza Virus Infection in Normal and Nude Mice , 1977, Infection and immunity.
[44] F. Ennis,et al. Influenza virus infection in nude mice. , 1976, The Journal of infectious diseases.
[45] J. Hurd,et al. Effect of cyclophosphamide on infections in mice caused by virulent and avirulent strains of influenza virus , 1975, Infection and immunity.
[46] F. Suzuki,et al. Effect of Antilymphocyte Serum on Influenza Virus Infection in Mice , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[47] R. Kirschstein,et al. Respiratory Diseases in Cyclophosphamide-Treated Mice II. Decreased Virulence of PR8 Influenza Virus , 1972, Infection and immunity.